The Oncosearch | Oncotarget

Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer Research Paper

Miriam S. Butler, Mani Roshan-Moniri, Michael Hsing, Desmond Lau, Ari Kim, Paul Yen, Marta Mroczek, Mannan Nouri, Scott Lien, Peter Axerio-Cilies, Kush Dalal, Clement Yau, Fariba Ghaidi, Yubin Guo, Takeshi Yamazaki, Sam Lawn, Martin E. Gleave, Cheryl Y. Gregory-Evans, Lawrence P. McIntosh, Michael E. Cox, Paul S. Rennie, Artem Cherkasov

Published Apr 15, 2017 · Vol. 8, No. 26 · pp. 42438-42454

Prospects of estrogen receptor Î² activation in the treatment of castration-resistant prostate cancer Research Paper

Julia Gehrig, Silke KaulfuÃŸ, Hubertus Jarry, Felix Bremmer, Mark Stettner, Peter Burfeind, Paul Thelen

Published Mar 23, 2017 · Vol. 8, No. 21 · pp. 34971-34979

The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells Research Paper

Francesco Morra, Francesco Merolla, Virginia Napolitano, Gennaro Ilardi, Caterina Miro, Simona Paladino, Stefania Staibano, Aniello Cerrato, Angela Celetti

Published Mar 22, 2017 · Vol. 8, No. 19 · pp. 31815-31829

Inhibiting G protein Î²Î³ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel Research Paper

Prakash Paudyal, Qing Xie, Prasanna Kuma Vaddi, Michael D. Henry, Songhai Chen

Published Mar 21, 2017 · Vol. 8, No. 22 · pp. 36067-36081

Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer Research Paper

Jennifer Podolak, Kristi Eilers, Timothy Newby, Rachel Slottke, Erin Tucker, Susan B. Olson, Hui-Wen Lue, Jack Youngren, Rahul Aggarwal, Eric J. Small, Julie N. Graff, Joshi J. Alumkal, Tomasz M. Beer, George V. Thomas

Published Mar 13, 2017 · Vol. 8, No. 42 · pp. 71447-71455

Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 Research Paper

Waseem Al-Jameel, Xiaojun Gou, Shiva S. Forootan, Majed Saad Al Fayi, Philip S. Rudland, Farzad S. Forootan, Jiacheng Zhang, Philip A. Cornford, Syed A. Hussain, Youqiang Ke

Published Mar 9, 2017 · Vol. 8, No. 19 · pp. 31041-31056

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death Research Paper

Ashkan Mortezavi, Souzan Salemi, Niels J. Rupp, Jan Hendrik RÃ¼schoff, Thomas Hermanns, Cedric Poyet, Marco Randazzo, Hans-Uwe Simon, Holger Moch, Tullio Sulser, Peter Wild, Daniel Eberli

Published Mar 7, 2017 · Vol. 8, No. 19 · pp. 31765-31774

Epithelial-mesenchymal transition in prostate cancer: an overview Review

Micaela Montanari, Sabrina Rossetti, Carla Cavaliere, Carmine Dâ€™Aniello, Maria Gabriella Malzone, Daniela Vanacore, Rossella Di Franco, Elvira La Mantia, Gelsomina Iovane, Raffaele Piscitelli, Raffaele Muscariello, Massimiliano Berretta, Sisto PerdonÃ, Paolo Muto, Gerardo Botti, Attilio Antonio Montano Bianchi, Bianca Maria Veneziani, Gaetano Facchini

Published Feb 25, 2017 · Vol. 8, No. 21 · pp. 35376-35389

Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions Research Paper

Marco Fioramonti, Daniele Santini, Michele Iuliani, Giulia Ribelli, Paolo Manca, Nicola Papapietro, Filippo Spiezia, Bruno Vincenzi, Vincenzo Denaro, Antonio Russo, Giuseppe Tonini, Francesco Pantano

Published Feb 16, 2017 · Vol. 8, No. 12 · pp. 20113-20121

Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes Research Paper

Leslimar RÃos-ColÃ³n, Christina K. Cajigas-Du Ross, Anamika Basu, Catherine Elix, Ivana Alicea-Polanco, Tino W. Sanchez, Vinodh Radhakrishnan, Chien-Shing Chen, Carlos A. Casiano

Published Feb 14, 2017 · Vol. 8, No. 15 · pp. 24915-24931

Upregulation of FAM84B during prostate cancer progression Research Paper

Nicholas Wong, Yan Gu, Anil Kapoor, Xiaozeng Lin, Diane Ojo, Fengxiang Wei, Judy Yan, Jason de Melo, Pierre Major, Geoffrey Wood, Tariq Aziz, Jean-Claude Cutz, Michael Bonert, Arthur J. Patterson, Damu Tang

Published Feb 7, 2017 · Vol. 8, No. 12 · pp. 19218-19235

Detection fidelity of AR mutations in plasma derived cell-free DNA Research Paper

Alexa Goldstein, Patricia Valda Toro, Justin Lee, John L. Silberstein, Mary Nakazawa, Ian Waters, Karen Cravero, David Chu, Rory L. Cochran, Minsoo Kim, Daniel Shinn, Samantha Torquato, Robert M. Hughes, Aparna Pallavajjala, Michael A. Carducci, Channing J. Paller, Samuel R. Denmeade, Bruce Kressel, Bruce Trock, Mario A. Eisenberger, Emmanuel S. Antonarakis, Ben H. Park, Paula J. Hurley

Published Jan 31, 2017 · Vol. 8, No. 9 · pp. 15651-15662

Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression Research Paper

Claire Tonry, John Armstrong, Stephen R. Pennington

Published Jan 12, 2017 · Vol. 8, No. 9 · pp. 14374-14394

Androgen receptor splice variants and prostate cancer: From bench to bedside Review

Kristine M. Wadosky, Shahriar Koochekpour

Published Jan 6, 2017 · Vol. 8, No. 11 · pp. 18550-18576

Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures Research Paper

Indranil Chattopadhyay, Jianmin Wang, Maochun Qin, Lingqiu Gao, Renae Holtz, Robert L. Vessella, Robert W. Leach, Irwin H. Gelman

Published Dec 31, 2016 · Vol. 8, No. 6 · pp. 10324-10347

A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer Research Paper

Dong Han, Shuai Gao, Kevin Valencia, Jude Owiredu, Wanting Han, Eric de Waal, Jill A. Macoska, Changmeng Cai

Published Dec 27, 2016 · Vol. 8, No. 4 · pp. 6796-6808

PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer Research Paper

Jianjun Sha, Wei Xue, Baijun Dong, Jiahua Pan, Xiaorong WU, Dong Li, Dongming Liu, Yiran Huang

Published Dec 20, 2016 · Vol. 8, No. 4 · pp. 6114-6129

Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors Research Paper

Shu Feng, Longjiang Shao, Patricia Castro, Ilsa Coleman, Peter S. Nelson, Paul D Smith, Barry R Davies, Michael Ittmann

Published Dec 20, 2016 · Vol. 8, No. 4 · pp. 6179-6192

MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling Research Paper

Anne Offermann, Ignacija Vlasic, Isabella Syring, Wenzel Vogel, Christian Ruiz, Tobias Zellweger, Cyrill A. Rentsch, Susanne Hagedorn, Jochen Behrends, Michael Nowak, Axel Merseburger, Lukas Bubendorf, Jutta Kirfel, Stefan Duensing, David Adler, Sven Perner

Published Dec 10, 2016 · Vol. 8, No. 5 · pp. 7964-7976

Sublethal exposure to alpha radiation (²²³Ra dichloride) enhances various carcinomasâ€™ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation Research Paper

Anthony S. Malamas, Sofia R. Gameiro, Karin M. Knudson, James W. Hodge

Published Nov 23, 2016 · Vol. 7, No. 52 · pp. 86937-86947

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer Research Paper

Prospects of estrogen receptor Î² activation in the treatment of castration-resistant prostate cancer Research Paper

The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells Research Paper

Inhibiting G protein Î²Î³ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel Research Paper

Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer Research Paper

Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 Research Paper

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death Research Paper

Epithelial-mesenchymal transition in prostate cancer: an overview Review

Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions Research Paper

Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes Research Paper

Upregulation of FAM84B during prostate cancer progression Research Paper

Detection fidelity of AR mutations in plasma derived cell-free DNA Research Paper

Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression Research Paper

Androgen receptor splice variants and prostate cancer: From bench to bedside Review

Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures Research Paper

A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer Research Paper

PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer Research Paper

Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors Research Paper

MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling Research Paper

Sublethal exposure to alpha radiation (²²³Ra dichloride) enhances various carcinomasâ€™ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer Research Paper

Prospects of estrogen receptor Î² activation in the treatment of castration-resistant prostate cancer Research Paper

The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells Research Paper

Inhibiting G protein Î²Î³ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel Research Paper

Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer Research Paper

Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 Research Paper

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death Research Paper

Epithelial-mesenchymal transition in prostate cancer: an overview Review

Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions Research Paper

Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes Research Paper

Upregulation of FAM84B during prostate cancer progression Research Paper

Detection fidelity of AR mutations in plasma derived cell-free DNA Research Paper

Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression Research Paper

Androgen receptor splice variants and prostate cancer: From bench to bedside Review

Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures Research Paper

A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer Research Paper

PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer Research Paper

Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors Research Paper

MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling Research Paper

Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomasâ€™ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation Research Paper

Sublethal exposure to alpha radiation (²²³Ra dichloride) enhances various carcinomasâ€™ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin-mediated immunogenic modulation Research Paper